The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
2023 · Molecular Cancer · 37 citations
https://doi.org/10.1186/s12943-023-01897-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
120
Citations
5
h-index
4
i10-index
Kensuke Hirosuna is an academic researcher from Osaka University of Pharmaceutical Sciences. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research. The author has an h-index of 5, co-authored 18 publications.
ORCID: 0000-0002-9263-4929https://doi.org/10.1186/s12943-023-01897-6
https://doi.org/10.3390/ijms25031486
Click to start Chat